GR3035589T3 - Novel CC-1065 analogs having two CPI subunits. - Google Patents

Novel CC-1065 analogs having two CPI subunits.

Info

Publication number
GR3035589T3
GR3035589T3 GR20010400433T GR20010400433T GR3035589T3 GR 3035589 T3 GR3035589 T3 GR 3035589T3 GR 20010400433 T GR20010400433 T GR 20010400433T GR 20010400433 T GR20010400433 T GR 20010400433T GR 3035589 T3 GR3035589 T3 GR 3035589T3
Authority
GR
Greece
Prior art keywords
pct
formula
date mar
compounds
analogs
Prior art date
Application number
GR20010400433T
Other languages
Greek (el)
English (en)
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GR3035589T3 publication Critical patent/GR3035589T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Amplifiers (AREA)
  • Artificial Filaments (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Stereophonic System (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Television Receiver Circuits (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Television Systems (AREA)
GR20010400433T 1988-09-12 2001-03-15 Novel CC-1065 analogs having two CPI subunits. GR3035589T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (1)

Publication Number Publication Date
GR3035589T3 true GR3035589T3 (en) 2001-06-29

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400433T GR3035589T3 (en) 1988-09-12 2001-03-15 Novel CC-1065 analogs having two CPI subunits.

Country Status (14)

Country Link
US (1) US5541339A (enExample)
JP (1) JP3380237B2 (enExample)
KR (1) KR0137959B1 (enExample)
AT (1) ATE198335T1 (enExample)
AU (1) AU632288B2 (enExample)
CA (1) CA1340215C (enExample)
DE (1) DE68929275T2 (enExample)
DK (1) DK175458B1 (enExample)
FI (1) FI103668B1 (enExample)
GR (1) GR3035589T3 (enExample)
LV (1) LV12806B (enExample)
NO (1) NO303498B1 (enExample)
TW (1) TW217383B (enExample)
WO (1) WO1990002746A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563475B1 (en) * 1992-03-25 2000-05-31 Immunogen Inc Cell binding agent conjugates of derivatives of CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
CA2447139C (en) 2001-05-11 2013-11-19 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
PL369771A1 (en) 2001-11-09 2005-05-02 Boehringer Ingelheim Pharmaceuticals, Inc. Benzimidazoles useful as protein kinase inhibitors
WO2004014905A1 (en) * 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
CA2501547A1 (en) * 2002-10-15 2004-04-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
US20070213374A1 (en) * 2003-07-07 2007-09-13 Merck Patent Gmbh Malonamide Derivatives
US20050209284A1 (en) * 2004-02-12 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Tec kinase inhibitors
MX2008002364A (es) * 2005-08-17 2008-03-18 Schering Corp Ligandos novedosos de cinasa basados en tiofeno y en furano de alta afinidad.
EP2126127B1 (en) 2007-01-25 2016-09-28 Dana-Farber Cancer Institute, Inc. Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
AU2008227123B2 (en) 2007-03-15 2014-03-27 Ludwig Institute For Cancer Research Ltd. Treatment method using EGFR antibodies and src inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
US9283276B2 (en) 2007-08-14 2016-03-15 Ludwig Institute For Cancer Research Ltd. Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
RU2628069C2 (ru) 2008-11-03 2017-08-14 Синтарга Б.В. Новые аналоги сс-1065 и их конъюгаты
UA112291C2 (uk) 2010-04-21 2016-08-25 Синтарґа Б.В. Кон'югати аналогів cc-1065 і біфункціональні лінкери
US20150265641A1 (en) 2012-10-22 2015-09-24 Arnold Glazier Methods for the Effective Treatment of Metastatic Cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
ES2687225T3 (es) 2014-01-10 2018-10-24 Synthon Biopharmaceuticals B.V. Método de purificación de conjugados anticuerpo-fármaco unidos a Cys
KR101871088B1 (ko) * 2014-01-27 2018-06-25 화이자 인코포레이티드 이관능성 세포독성제
ES2785551T3 (es) 2014-06-30 2020-10-07 Glykos Finland Oy Derivado de sacárido de una carga útil tóxica y sus conjugados con anticuerpos
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
AU2016238551B2 (en) * 2015-03-20 2020-01-02 Pfizer Inc. Bifunctional cytotoxic agents containing the CTI pharmacophore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
DE3750612T2 (de) * 1986-12-19 1995-03-02 Upjohn Co Cc-1065 analoge.

Also Published As

Publication number Publication date
LV12806B (lv) 2002-05-20
JP3380237B2 (ja) 2003-02-24
NO910958D0 (no) 1991-03-11
JPH04500664A (ja) 1992-02-06
TW217383B (enExample) 1993-12-11
KR900701801A (ko) 1990-12-04
DE68929275D1 (de) 2001-02-01
KR0137959B1 (ko) 1998-05-15
NO910958L (no) 1991-05-10
DK41791A (da) 1991-03-08
FI103668B (fi) 1999-08-13
AU632288B2 (en) 1992-12-24
AU4192289A (en) 1990-04-02
FI103668B1 (fi) 1999-08-13
WO1990002746A1 (en) 1990-03-22
NO303498B1 (no) 1998-07-20
LV12806A (en) 2002-03-20
DK41791D0 (da) 1991-03-08
CA1340215C (en) 1998-12-15
ATE198335T1 (de) 2001-01-15
FI911193A0 (fi) 1991-03-11
DE68929275T2 (de) 2001-05-23
DK175458B1 (da) 2004-11-01
US5541339A (en) 1996-07-30

Similar Documents

Publication Publication Date Title
GR3035589T3 (en) Novel CC-1065 analogs having two CPI subunits.
TR200000197T2 (tr) Yeni bileşimler
DK0631575T3 (da) Substituerede pyrimidiner samt deres anvendelse som fungicider
ATE112279T1 (de) Cc-1065 analoge.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
FI865233A0 (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
DE3774286D1 (de) (2,2-bis(aminomethyl)-1,3-propandiol-n,n')platin-komplexe.
ES2153814T3 (es) Analogos de cc-1065 que tienen dos subunidades cpi.
SE9802574D0 (sv) Novel compounds
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DE3879478D1 (de) Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen.
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
IT1213034B (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
ES2013695B3 (es) Compuestos de coordinacion de platino
DE3772909D1 (de) 3-methylphthalimide.
ES2083608T3 (es) Sintesis asimetrica de los compuestos furanosidos 3-sustituidos.
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
ATE87314T1 (de) Platin-arzneimittel.
DK0544168T3 (da) Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler
FR2665362B1 (fr) Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
FR2574798B1 (fr) Nouvelle adenosine substituee en n6 et medicament la contenant comme principe actif
ATE73444T1 (de) Chemische zusammensetzungen und verwendung als brennstoff-additive.
GT199400074A (es) Pirroles substituidos

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees